BioMed Realty has acquired Denny Park South in Seattle, a 1.6-acre development site in the South Lake Union/Denny Triangle district. The two-parcel site will accommodate a 616,000-square-foot development for a life science use.

The purchase of this development site is a prize addition to BioMed's substantial portfolio in the Seattle area. BioMed owns a 1.2 million-square-foot portfolio in Seattle, including the recently completed flagship Dexter Yard project in South Lake Union. The acquisition of Denny Park South, as well as with the T6 Innovation Center at 200 Taylor Avenue North, a similarly 1.8-acre, two-parcel development site that the firm purchased last year, represent 1.2 million square feet of development potential. In total, the company has 2.4 million square feet of assets or developments in the Seattle area.

The firm's portfolio is leased to Seattle Children's Research Institute, Novo Nordisk, Omeros Corporation, InBios International, Inc., Lyell Immunopharma, Inc., Shape Therapeutics and Tableau.